The drink that kept us going through Covid-19
One of the world’s most popular beverages has overcome remarkable hurdles to carry on during the pandemic. What does i...
You are offline
Good Health and Well-being
SII to sell first 100 million doses of COVID-19 vaccine at ₹200 per dose
Mr. Poonawalla said the company been barred from exporting the vaccine for several months.Serum Institute of India will be selling the first 100 million doses of its coronavirus vaccines to the Union government at a “special price†of ₹200, the comapny’s CEO Adar Poonawalla has said.The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.On Sunday, Drug Controller General of India (DCGI) approved Covishield and Bharat Biotech's Covaxin for restricted emergency use.In a phone interview with The Associated Press, Mr. Poonawalla said the company been barred from exporting the vaccine for several months. Selling the vaccine on the private market has also been barred.
View SourceRelated Notices
WHO: 9 in 10 African countries to miss COVID-19 vaccination goal
On Thursday, the WHO stated that about 90% of African countries will not reach the September target to get at least 10% ...
Centre tells States, UTs to prioritise beneficiaries waiting for second dose of COVID-19 vaccine
States and Union Territories have been asked to prioritise the beneficiaries of the second dose of the COVID-19 vaccine...
This notice has been removed
The content is no longer available
SII to sell first 100 million doses of COVID-19 vaccine at ₹200 per dose
Mr. Poonawalla said the company been barred from exporting the vaccine for several months.Serum Institute of India will be selling the first 100 million doses of its coronavirus vaccines to the Union government at a “special price†of ₹200, the comapny’s CEO Adar Poonawalla has said.The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.On Sunday, Drug Controller General of India (DCGI) approved Covishield and Bharat Biotech's Covaxin for restricted emergency use.In a phone interview with The Associated Press, Mr. Poonawalla said the company been barred from exporting the vaccine for several months. Selling the vaccine on the private market has also been barred.
Recent Searches
Recent Noticeboards
Trending
No results found
Try a different search term
Something went wrong
No notices yet
No notices match these filters
Couldn't load notices
You're all caught up 🎉
Discussion (0)
No comments yet